Northeast Investment Management / TMO
Northeast Investment Management’s Thermo Fisher Scientific Inc Position
Does Northeast Investment Management own Thermo Fisher Scientific Inc (TMO)? Yes — 81.7K shares worth $40M (+1.66% of its 13F portfolio) as of Q1 2026, down from 82.8K shares the prior filed quarter.
Position Value
$40M
Q1 2026
Shares
81.7K
% of Portfolio
+1.66%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 81.7K | $40M | +1.66% |
| Q4 2025 | 82.8K | $48M | +1.88% |
| Q3 2025 | 83.4K | $40M | +1.63% |
| Q2 2025 | 85.0K | $34M | +1.47% |
| Q1 2025 | 86.0K | $43M | +1.99% |
| Q4 2024 | 86.5K | $45M | +2.00% |
| Q3 2024 | 86.8K | $54M | +2.41% |
| Q2 2024 | 87.0K | $48M | +2.26% |
| Q1 2024 | 87.4K | $51M | +2.50% |
| Q4 2023 | 88.3K | $47M | +2.51% |
| Q3 2023 | 89.0K | $45M | +2.65% |
| Q2 2023 | 89.4K | $47M | +2.63% |
| Q1 2023 | 91.4K | $53M | +3.20% |
| Q4 2022 | 93.7K | $51,597 | +3.29% |
| Q3 2022 | 95.5K | $48M | +3.28% |
| Q2 2022 | 96.8K | $53M | +3.35% |
| Q1 2022 | 98.7K | $58M | +3.07% |
| Q4 2021 | 101.0K | $67M | +3.29% |
| Q3 2021 | 103.4K | $59M | +3.16% |
| Q2 2021 | 106.4K | $54M | +2.89% |
| Q1 2021 | 109.8K | $50M | +2.96% |
| Q4 2020 | 112.8K | $53M | +3.20% |
| Q3 2020 | 117.3K | $52M | +3.44% |
| Q2 2020 | 116.9K | $42M | +3.17% |
| Q1 2020 | 116.6K | $33M | +3.04% |
| Q4 2019 | 118.4K | $38M | +2.83% |
| Q3 2019 | 119.7K | $35M | +2.79% |
| Q2 2019 | 120.6K | $35M | +2.81% |
| Q1 2019 | 121.3K | $33M | +2.79% |
| Q4 2018 | 120.9K | $27M | +2.60% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Northeast Investment Management’s full portfolio or all institutional holders of TMO.